Please Enable Cookies

www.cablinginstall.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Morgan Stanley 22nd Annual Global Healthcare Conference
1x1 Investor Meetings: Friday, September 6, 2024
Location: New York, NY

Baird 2024 Global Healthcare Conference
Fireside Chat: Wednesday, September 11, 2024, at 7:55am ET
Location: New York, NY

Chardan’s 8th Annual Genetic Medicines Conference
Fireside Chat: Monday, September 30, 2024, at 4:30pm ET
Location: New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.